Systematic Alpha Investments’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.57M Hold
29,701
0.09% 79
2025
Q4
$2.85M Hold
29,701
0.09% 74
2025
Q3
$2.83M Hold
29,701
0.09% 76
2025
Q2
$2.59M Hold
29,701
0.09% 74
2025
Q1
$2.67M Hold
29,701
0.1% 72
2024
Q4
$2.37M Hold
29,701
0.09% 75
2024
Q3
$2.67M Hold
29,701
0.1% 70
2024
Q2
$2.34M Hold
29,701
0.09% 73
2024
Q1
$2.59M Hold
29,701
0.1% 69
2023
Q4
$2.45M Hold
29,701
0.11% 68
2023
Q3
$2.33M Hold
29,701
0.12% 69
2023
Q2
$2.62M Hold
29,701
0.13% 66
2023
Q1
$2.39M Hold
29,701
0.13% 68
2022
Q4
$2.31M Hold
29,701
0.12% 69
2022
Q3
$2.4M Hold
29,701
0.14% 66
2022
Q2
$2.67M Hold
29,701
0.15% 67
2022
Q1
$3.29M Hold
29,701
0.16% 67
2021
Q4
$3.07M Hold
29,701
0.14% 72
2021
Q3
$3.56M Hold
29,701
0.16% 68
2021
Q2
$3.72M Buy
29,701
+601
+2% +$75.5K 0.17% 65
2021
Q1
$3.44M Buy
+29,100
New +$3.41M 0.22% 60

Other funds holding MDT

Systematic Alpha Investments's MDT Position: Q1 2026 in Review

Systematic Alpha Investments held its Medtronic (MDT) position steady in Q1 2026 at 29,701 shares worth $2.57M. The position accounts for 0.09% of the portfolio, ranked #79.

Systematic Alpha Investments first reported a position in MDT in Q1 2021 and has held it in 21 quarters since. The position peaked at $3.72M in Q2 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Systematic Alpha Investments held 29,701 shares of Medtronic worth $2.57M as of Q1 2026.
  • Systematic Alpha Investments left its Medtronic share count unchanged in Q1 2026.
  • Medtronic made up 0.09% of Systematic Alpha Investments's portfolio in Q1 2026, its #79 holding.
  • Systematic Alpha Investments first reported a position in Medtronic in Q1 2021 and has held it in 21 quarters since.
  • Systematic Alpha Investments's Medtronic position peaked at $3.72M in Q2 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Systematic Alpha Investments's 13F filing for Q1 2026, filed 18 May 2026.